Efflux of novel quinolones in contemporary Streptococcus pneumoniae isolates from community-acquired pneumonia

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 948-951

  Lismond, Ann ^a   Carbonnelle, Sylviane ^a,b   Tulkens, Paul M ^a   van Bambeke, Françoise ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Centre communautaire de référence pour le dépistage des cancers a s b l   (Belgium)

Author keywords

Ciprofloxacin; Garenoxacin; Gemifloxacin; Levofloxacin; Moxifloxacin; Reserpine

Indexed keywords

CIPROFLOXACIN; GARENOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLONE; RESERPINE;

ANTIBIOTIC SENSITIVITY; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, PNEUMOCOCCAL; QUINOLONES; STREPTOCOCCUS PNEUMONIAE;

EID: 79952807465     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr004     Document Type: Letter

References (6)

1. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-80.
2. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2: S27-72.
3. Pletz MW, van der Linden M, von Baum H et al. Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage. Int J Med Microbiol 2011; 301: 53-7.
4. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 1999 Suppl 2; 58: 11-8.
5. Garvey MI, Baylay AJ, Wong RL et al. Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2011; 55: 190-6.
6. Avrain L, Garvey M, Mesaros N et al. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. J Antimicrob Chemother 2007; 60: 965-72.